Considerations related to the use of recombinant human growth hormone in children

Jr Berlin, D. G. McCarver-May, D. A. Notterman, R. M. Ward, D. N. Weismann, G. S. Wilson, J. T. Wilson, E. B. Weller, D. R. Bennett, J. Mulinare, I. A. Hoskins, P. Kaufman, C. Krough, M. J. Rieder, G. Troendler, S. J. Yaffe, C. J. Cote, S. J. Szefler, J. L. Blumer

Research output: Contribution to journalReview article

49 Scopus citations

Abstract

Since 1985 molecular biology techniques have made possible the synthetic synthesis of pure human growth hormone in potentially unlimited amounts. With this increased availability its use in patients other than children with growth hormone deficiency has been associated with clinical ethical questions. This statement presents an analysis of the current status of the use of human growth hormone in children.

Original languageEnglish (US)
Pages (from-to)122-129
Number of pages8
JournalPediatrics
Volume99
Issue number1
DOIs
StatePublished - 1997

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Considerations related to the use of recombinant human growth hormone in children'. Together they form a unique fingerprint.

Cite this